| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.4M | -3.6% | -23.8% |
| R&D Expense | $2.1M | -8.2% | -36.0% |
| SG&A Expense | $13.9M | +22.2% | +30.9% |
| Operating Income | -$9.7M | -31.1% | -43.0% |
| Interest Expense | $3.7M | -14.8% | -33.8% |
| Pre-tax Income | -$25.1M | -78.4% | -61.3% |
| Income Tax | -$237K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $26.7M | -21.5% | +3.9% |
| Short-term Investments | $4.5M | +0.1% | -35.9% |
| Accounts Receivable | $9.7M | +3.8% | -13.7% |
| Current Assets | $49.1M | -13.4% | -9.7% |
| Total Assets | $273.9M | -5.0% | -19.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.2M | — | — |
| Investing Cash Flow | $41.4M | — | — |
| Financing Cash Flow | -$32.4M | — | — |
| +70.2% |
| +61.8% |
| Net Income | -$24.9M | -87.3% | -66.4% |
| EPS (Basic) | -$1.73 | -2062.5% | -1472.7% |
| EPS (Diluted) | -$1.73 | -2062.5% | -1472.7% |
| $48.5M |
| +6.9% |
| -27.3% |
| Long-term Debt | $131.5M | +12.6% | -13.6% |
| Total Liabilities | $198.4M | +4.1% | -17.2% |
| Stockholders' Equity | $75.5M | -20.6% | -23.4% |